<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f2 { font-family:sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f3 { font-family:ff8,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f4 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f5 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f6 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f7 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f8 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f9 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f10 { font-family:ff6,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f11 { font-family:ff7,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="841" src="page13.png">
<div class="txt" style="position:absolute; left:191px; top:111px;"><span id="f5" style="font-size:18px;vertical-align:baseline;color:rgba(85,146,206,1);">III. SK</span><span id="f6" style="font-size:18px;vertical-align:baseline;color:rgba(85,146,206,1);">바이오텍</span></div>
<div class="txt" style="position:absolute; left:56px; top:179px;"><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">아웃소싱</span></div>
<div class="txt" style="position:absolute; left:56px; top:195px;"><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">수요 급격히 증가 중</span></div>
<div class="txt" style="position:absolute; left:191px; top:151px;"><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">1. </span><span id="f6" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">글로벌 </span><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">CDMO </span><span id="f6" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">사업현황</span></div>
<div class="txt" style="position:absolute; left:191px; top:178px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">는 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">사업체 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오텍 지분을 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">100% </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">보유 중이다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. CDMO(Contract</span></div>
<div class="txt" style="position:absolute; left:191px; top:194px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Development and Manufacturing Organization)</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">란 항체의약품 위탁생산</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(CMO)</span></div>
<div class="txt" style="position:absolute; left:191px; top:210px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">과 위탁개발</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(CDO)</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이 모두 가능한 바이오 업체이다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">신약개발에 집중하기 위해</span></div>
<div class="txt" style="position:absolute; left:191px; top:226px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 빅파마들은 생산 외주를 확대</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">신생 제약사의 신약개발이 활발해지면서</span></div>
<div class="txt" style="position:absolute; left:191px; top:242px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">아웃소싱 수요가 급격히 증가 중이다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:56px; top:275px;"><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 경구용 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">시장</span></div>
<div class="txt" style="position:absolute; left:56px; top:291px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2015~2020</span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">년 연평균 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2.5%</span></div>
<div class="txt" style="position:absolute; left:56px; top:307px;"><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">성장 전망</span></div>
<div class="txt" style="position:absolute; left:191px; top:274px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Specialty </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">신약</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">제네릭 의약품 소비 증가</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">제약업체의 아웃소싱 증가로 글로벌</span></div>
<div class="txt" style="position:absolute; left:191px; top:290px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO(</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">경구용 기준</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">) </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">시장은 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2015</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">77</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러에서 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2020</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">87</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러로 연평균</span></div>
<div class="txt" style="position:absolute; left:191px; top:306px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2.5% </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">성장할 전망이다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. CDMO</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">시장은 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">4</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">천여개의 업체들이 존재하나 기술력과 캐</span></div>
<div class="txt" style="position:absolute; left:191px; top:322px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">파를 갖춘 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">top-tier </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">업체는 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">개 정도로 대규모 자본</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">높은 기술이 동시에 요구된</span></div>
<div class="txt" style="position:absolute; left:191px; top:338px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">성공적인 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">도약을 위해서는 임상 초기 단계부터 상업수주 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">lock-</span></div>
<div class="txt" style="position:absolute; left:191px; top:354px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">in(Development-</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">임상물량공급</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상업화 스케일업</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">) </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">가능 여부</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, FDA </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">등 글로벌</span></div>
<div class="txt" style="position:absolute; left:191px; top:370px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">규제 기관의 기준에 부합하는 기술력</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">대형 고객사 대응을 위한 캐파가 필수적이</span></div>
<div class="txt" style="position:absolute; left:191px; top:386px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">대규모 자본력</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">중장기 투자</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, CEO</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 의지가 핵심인 만큼 </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">가 강점을 드러</span></div>
<div class="txt" style="position:absolute; left:191px; top:402px;"><span id="f7" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">낼 수 있는 사업이다</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:193px; top:435px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">[</span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">그림 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">10] </span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">시장 전망</span></div>
<div class="txt" style="position:absolute; left:224px; top:460px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f11" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">십억달러</span><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:204px; top:470px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">150</span></div>
<div class="txt" style="position:absolute; left:204px; top:512px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:271px; top:531px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">66</span></div>
<div class="txt" style="position:absolute; left:273px; top:542px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">4</span></div>
<div class="txt" style="position:absolute; left:208px; top:554px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">50</span></div>
<div class="txt" style="position:absolute; left:271px; top:551px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">17</span></div>
<div class="txt" style="position:absolute; left:271px; top:578px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(255,255,255,1);">45</span></div>
<div class="txt" style="position:absolute; left:212px; top:597px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:267px; top:605px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2015</span></div>
<div class="txt" style="position:absolute; left:191px; top:624px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: SK, </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:393px; top:464px;"><span id="f11" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">합성</span><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">API DP </span><span id="f11" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오</span><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">API </span><span id="f11" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">합계</span></div>
<div class="txt" style="position:absolute; left:470px; top:480px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">127</span></div>
<div class="txt" style="position:absolute; left:348px; top:491px;"><span id="f10" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">+6.8%</span></div>
<div class="txt" style="position:absolute; left:472px; top:494px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">12</span></div>
<div class="txt" style="position:absolute; left:372px; top:509px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">93</span></div>
<div class="txt" style="position:absolute; left:472px; top:515px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">38</span></div>
<div class="txt" style="position:absolute; left:374px; top:521px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">8</span></div>
<div class="txt" style="position:absolute; left:372px; top:535px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">25</span></div>
<div class="txt" style="position:absolute; left:472px; top:564px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(255,255,255,1);">77</span></div>
<div class="txt" style="position:absolute; left:372px; top:571px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(255,255,255,1);">60</span></div>
<div class="txt" style="position:absolute; left:365px; top:605px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2020F</span></div>
<div class="txt" style="position:absolute; left:466px; top:605px;"><span id="f10" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2025F</span></div>
<div class="txt" style="position:absolute; left:191px; top:652px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;</span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">표 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">10&gt; </span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">의약품 품목별 </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">시장 전망</span></div>
<div class="txt" style="position:absolute; left:191px; top:670px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">제품 형태</span></div>
<div class="txt" style="position:absolute; left:191px; top:681px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">시장규모</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(2015 </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년→</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2020 </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:191px; top:693px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">연평균성장률</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(2015~2020 </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:361px; top:670px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주사제</span></div>
<div class="txt" style="position:absolute; left:344px; top:681px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6.5 </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">→ </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">12.8</span></div>
<div class="txt" style="position:absolute; left:367px; top:693px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">14.6</span></div>
<div class="txt" style="position:absolute; left:191px; top:707px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: SK, </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:439px; top:670px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">경구제</span></div>
<div class="txt" style="position:absolute; left:426px; top:681px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">7.7 </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">→ </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">8.7</span></div>
<div class="txt" style="position:absolute; left:449px; top:693px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2.5</span></div>
<div class="txt" style="position:absolute; left:478px; top:655px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">단위</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억달러</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, %)</span></div>
<div class="txt" style="position:absolute; left:524px; top:670px;"><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">기타</span></div>
<div class="txt" style="position:absolute; left:504px; top:681px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2.7 </span><span id="f9" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">→ </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">3.0</span></div>
<div class="txt" style="position:absolute; left:527px; top:693px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1.3</span></div>
<div class="txt" style="position:absolute; left:62px; top:802px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(128,128,128,1);">12</span></div>
</body>
</html>
